The Roger Greenhalgh Vascular Foundation

Registered charity 326971 · accounts filings on the Charity Commission register · also known as THE AFG ARTERIAL DISEASE RESEARCH FOUNDATION, THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION, THE NISSAN UK ARTERIAL DISEASE RESEARCH FOUNDATION

Funding medical research

Causes: The Advancement Of Health Or Saving Of Lives · Get email alerts

Latest income
£339k
Latest spending
£32k
Registered
1985
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that unrestricted reserves stood at £2,265,320, which is above the trustees' stated policy target of £1 million. The charity reported a surplus of £483,951 for the year, driven by a significant investment revaluation gain of £176,545 alongside donations and investment income.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: £1 million (held: £2.3m)
“The Trustees aim to maintain reserves of £1 million to preserve the continuity of the Foundation for the foreseeable future.” — page 5
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/07/2025£339k£32k
31/07/2024£74k£4k
31/07/2023£68k£10k
31/07/2022£63k£10k
31/07/2021£61k£34k

Common questions

Is The Roger Greenhalgh Vascular Foundation financially healthy?

Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £2,265,320, which is above the trustees' stated policy target of £1 million. The charity reported a surplus of £483,951 for the year, driven by a significant investment revaluation gain of £176,545 alongside donations and investment income. Its FY2025 accounts were independently examined.